Skip to main content

Table 3 Results of analysis of PSA-PFS by Cox proportional hazards model

From: Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

   

Univariate

  

Multivariate

 
  

Hazard-ratio

p

95 % CI

Hazard-ratio

p

95 % CI

Age

≤75

1

     

76≤

1.213

0.232

0.884- 1.666

   

Stage

B

1

     

C

1.283

0.157

0.908-1.813

   

PSA level at diagnosis

<20

1

  

1

  

20≤

2.048

<0.001

1.500-2.797

1.613

0.071

0.959-2.711

Gleason score

≤7

1

  

1

  

8≤

1.734

0.001

1.256-2.393

1.436

0.064

0.979-2.107

Laterality of cancer detected by biopsy

unilateral

1

  

1

  

bilateral

2.102

<0.001

1.533- 2.883

1.523

0.034

1.033-2.245

SVI

Negative

1

  

1

  

Positive

1.71

0.032

1.046- 2.793

1.109

0.753

0.582-2.113

  1. PSA-PFS: PSA progression-free survival
  2. 95 % CI: 95 % confidence interval
  3. SVI: seminal vesicle involvement